Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to ZNF304 (ENSG00000268678)
- Target
- ENSG00000268678
- Molecular classification
- Other (Antisense non-coding RNA / long non-coding RNA)
01
Overview
ENSG00000268678 is a poorly characterized, long non-coding RNA (lncRNA) transcript that is antisense to the known gene ZNF304. As a member of natural antisense transcripts (NATs), it is transcribed from the opposite DNA strand relative to the sense gene (ZNF304). Antisense transcripts can regulate gene expression through mechanisms such as transcriptional interference, altering chromatin structure, and affecting RNA processing or stability of the sense transcript. There is no direct evidence that this particular antisense transcript has a defined function or clinical relevance, nor has it been established as a therapeutic target. It is best categorized as a genomic feature of uncertain significance, typical for many lncRNAs annotated in the human genome.
- Other names
- ENSG00000268678Novel transcript, antisense to ZNF304
02
Biological functions
Regulation of sense transcription (ZNF304)Chromatin modification influencePotential RNA masking or interferenceTranscript stability regulation
03
Disease associations
Other (no direct or established link to major disease categories; roles, if any, are hypothetical or uncharacterized due to the transcript's poorly defined function)
Beyond the preview
Go deeper on Novel transcript, antisense to ZNF304 (ENSG00000268678).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to ZNF304 (ENSG00000268678).